{"gene":"BAG5","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2004,"finding":"BAG5 directly interacts with parkin and Hsp70. Within this complex, BAG5 inhibits parkin E3 ubiquitin ligase activity and Hsp70-mediated refolding of misfolded proteins. BAG5 enhances parkin sequestration within protein aggregates and mitigates parkin-dependent preservation of proteasome function, enhancing dopamine neuron death in an in vivo PD model.","method":"Co-immunoprecipitation, in vitro ubiquitin ligase assay, in vivo dopamine neuron loss model, dominant-negative BAG5 mutant rescue","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interactions confirmed, in vitro enzymatic assay, in vivo model with mutant rescue; replicated conceptually by multiple subsequent studies","pmids":["15603737"],"is_preprint":false},{"year":2010,"finding":"The fifth BAG domain (BD5) of BAG5 is responsible for interaction with the Hsp70 nucleotide-binding domain (NBD). Crystal structures of the BD5-NBD complex reveal that BD5 binding causes conformational changes in the NBD that disrupt the nucleotide-binding groove, reducing NBD affinity for ADP. BD5 and full-length BAG5 accelerate Hsp70-mediated refolding in vitro, establishing BAG5 as a nucleotide exchange factor (NEF) for Hsp70.","method":"Crystal structure determination, in vitro ADP-binding affinity assay, in vitro protein refolding assay","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation (ADP affinity assay + refolding assay), multiple orthogonal methods in one study","pmids":["20223214"],"is_preprint":false},{"year":2011,"finding":"BAG5 forms a protein complex with CHIP (E3 ubiquitin ligase) and alpha-synuclein in brain, mediated by Hsp70 binding to CHIP's TPR domain and BAG5's BAG domains. BAG5 inhibits CHIP E3 ubiquitin ligase activity toward alpha-synuclein, reducing alpha-synuclein ubiquitinylation and thereby increasing alpha-synuclein oligomerization.","method":"Co-immunoprecipitation from brain tissue, in vitro ubiquitinylation assay, luciferase protein-fragment complementation assay of alpha-synuclein oligomerization","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro ubiquitinylation assay combined with co-IP from brain and live-cell oligomerization assay; multiple orthogonal methods in single lab","pmids":["21358815"],"is_preprint":false},{"year":2013,"finding":"BAG5 interacts with the ER-resident chaperone GRP78/BiP and enhances its ATPase activity. During ER stress, BAG5 relocates from the cytoplasm to the ER and inhibits ER-stress-induced apoptosis by suppressing the PERK-eIF2-ATF4 axis while enhancing the IRE1-Xbp1 axis of the unfolded protein response.","method":"Co-immunoprecipitation, ATPase activity assay, subcellular fractionation/relocalization, siRNA knockdown and overexpression with apoptosis readouts","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus ATPase assay plus pathway analysis; single lab with multiple orthogonal methods","pmids":["23448667"],"is_preprint":false},{"year":2014,"finding":"BAG5 directly interacts with PINK1, stabilizes PINK1 by decreasing its ubiquitination, and thereby protects against mitochondrial dysfunction induced by MPP+ and rotenone.","method":"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, ubiquitination assay, cell viability assay with mitochondrial toxins","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid and pulldown for interaction, ubiquitination assay for mechanism; single lab with multiple orthogonal methods","pmids":["24475098"],"is_preprint":false},{"year":2013,"finding":"BAG5, as an inhibitor of CHIP E3 ubiquitin ligase activity, reduces CHIP-mediated ubiquitination and degradation of PTEN, thereby maintaining PTEN protein levels via a ubiquitylation-dependent pathway.","method":"Co-immunoprecipitation, ubiquitination assay, western blot","journal":"BMB reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, mechanistic inference from CHIP inhibition; limited orthogonal validation","pmids":["24148769"],"is_preprint":false},{"year":2014,"finding":"BAG2 and BAG5 stabilize pathogenic ataxin3-80Q by inhibiting its ubiquitination, as shown by co-immunofluorescence and western blotting experiments.","method":"Co-immunofluorescence, western blotting, ubiquitination assay","journal":"The International journal of neuroscience","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, limited mechanistic detail in abstract, no direct binding assay described","pmids":["25006867"],"is_preprint":false},{"year":2016,"finding":"BAG5 interacts with mutant p53 (mutp53) proteins and protects mutp53 from ubiquitination and degradation by E3 ubiquitin ligases MDM2 and CHIP, leading to mutp53 accumulation and gain-of-function activities including increased cell proliferation, tumor growth, cell migration, and chemoresistance.","method":"Co-immunoprecipitation, ubiquitination assay, siRNA knockdown and overexpression with proliferation/migration/tumor growth assays","journal":"Cell discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus ubiquitination assay plus functional readouts; single lab with multiple orthogonal methods","pmids":["27807478"],"is_preprint":false},{"year":2017,"finding":"BAG5 interacts with DJ-1 in mammalian cells, decreases DJ-1 stability, and weakens DJ-1's role in mitochondrial protection, possibly by influencing DJ-1 dimerization under stress conditions.","method":"Co-immunoprecipitation, immunofluorescence, western blot","journal":"Oxidative medicine and cellular longevity","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, co-IP and immunofluorescence only, mechanism of dimerization effect not directly demonstrated","pmids":["28348719"],"is_preprint":false},{"year":2019,"finding":"BAG5 impairs Parkin-dependent mitophagy by suppressing Parkin recruitment to damaged mitochondria and reducing movement of damaged mitochondria into lysosomes. BAG5 also enhances Parkin-mediated Mcl-1 degradation and cell death following severe mitochondrial insult, suggesting BAG5 regulates the bi-modal activity of Parkin.","method":"Live-cell imaging of mitochondrial recruitment, lysosomal colocalization assay, cell death assays, Mcl-1 degradation assay","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization imaging with functional consequence, multiple cellular assays; single lab","pmids":["31787745"],"is_preprint":false},{"year":2020,"finding":"BAG5 interacts with p62/SQSTM1, enhances formation of pathogenic alpha-synuclein oligomers, and regulates the levels and subcellular distribution of p62, bridging the chaperone network to autophagy-mediated protein degradation.","method":"Co-immunoprecipitation, alpha-synuclein oligomerization assay, subcellular fractionation/immunofluorescence","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP plus oligomerization assay plus localization data; single lab, multiple methods","pmids":["32850835"],"is_preprint":false},{"year":2020,"finding":"Stress-induced p53 binds directly to the BAG5 promoter to stimulate BAG5 expression. Induced BAG5 binds alpha-synuclein and Hsp70 in cell cultures and PD patient brain lysates, and BAG5 expression is required for alpha-synuclein aggregation in SH-SY5Y cells.","method":"ChIP assay (p53 binding to BAG5 promoter), co-immunoprecipitation from brain lysates, siRNA knockdown with aggregation readout","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct promoter binding, co-IP from patient brain lysates, loss-of-function aggregation assay; single lab","pmids":["33085644"],"is_preprint":false},{"year":2020,"finding":"PRMT6 physically interacts with and methylates BAG5, and this methylation enhances degradation of BAG5's binding partner HSC70. PRMT6 deficiency leads to increased BAG5-associated HSC70 stability, promoting autophagy and tumorigenicity in hepatocellular carcinoma.","method":"Co-immunoprecipitation, methylation assay, genetic knockdown of BAG5 with in vivo tumor model","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus post-translational modification assay plus in vivo rescue; single lab","pmids":["33186656"],"is_preprint":false},{"year":2022,"finding":"Loss-of-function mutations in BAG5 cause inherited dilated cardiomyopathy. BAG5 acts as a nucleotide exchange factor for HSC70, promoting ADP release and activating HSC70-mediated protein folding. BAG5 localizes to junctional membrane complexes (JMCs) in cardiomyocytes; its loss disrupts JMC structure and calcium handling. AAV9-mediated wild-type BAG5 gene delivery fully rescues the DCM phenotype in knock-in mice.","method":"Human genetics (homozygous truncating mutations), knock-in mouse model, immunocytochemistry for JMC localization, calcium handling assays, AAV9 gene rescue","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — human genetics with complete penetrance, knock-in mouse phenocopying, localization with functional consequence, gene rescue; multiple orthogonal methods across labs","pmids":["35044787"],"is_preprint":false},{"year":2020,"finding":"BAG5 modulates fibronectin 1 (FN1) expression at the translational level in papillary thyroid cancer cells, promoting invasion via suppression of miR-144-3p, which targets the 3' UTR of FN1 transcript.","method":"BAG5 overexpression/knockdown, western blot and polysome fractionation for translational regulation, invasion assay, miR-144-3p functional assay","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mechanistic details on translational regulation are limited in abstract; single lab","pmids":["32275930"],"is_preprint":false},{"year":2024,"finding":"BAG5 forms a complex with HSPA8 in spermatids and promotes folding of SPATA6 (a sperm head-tail coupling apparatus component) by enhancing HSPA8's affinity for substrate proteins. BAG5-deficient male mice show misfolded SPATA6, MYO5A, MYL6, DYNLT1, DCTN1, and DNAL1, leading to aberrant HTCA assembly, acephalic spermatozoa syndrome, and male infertility.","method":"BAG5 knockout mouse model, co-immunoprecipitation, in vitro chaperone substrate-affinity assay, immunofluorescence of spermatid assembly","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — KO mouse with defined phenotype, co-IP, in vitro chaperone assay demonstrating mechanism; multiple orthogonal methods in one rigorous study","pmids":["38454159"],"is_preprint":false},{"year":2023,"finding":"BAG5 interacts with Akt at the linker region between its first and second BAG domains, and Akt phosphorylates BAG5's first BAG domain. BAG5 switches Akt from monoubiquitination to polyubiquitination (together with Hsp70), promoting Akt degradation. The BAG5-Akt complex forms under serum-starved conditions and dissociates upon HGF stimulation, coincident with BAG5 phosphorylation.","method":"Co-immunoprecipitation, ubiquitination assay, BAG5 knockdown/overexpression with Akt stability readouts, deletion mapping of interaction domain","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mapping, ubiquitination switch assay, loss/gain of function; single lab with multiple orthogonal methods","pmids":["38139359"],"is_preprint":false},{"year":2010,"finding":"BAG5 directly interacts with Parkin through all four BAG domains and stabilizes Parkin protein by interfering with its degradation via the ubiquitin-mediated proteasomal pathway.","method":"GST pulldown, co-immunoprecipitation, cycloheximide chase/ubiquitination assay","journal":"Zhong nan da xue xue bao. Yi xue ban","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pulldown and co-IP with chase experiment; single lab, limited methodological detail in abstract","pmids":["21131737"],"is_preprint":false},{"year":2025,"finding":"BAG5 interacts with HSPA2 (testis-specific HSP70 family member) in spermatocytes. BAG5 deficiency reduces HSPA2 levels, leading to germ cell apoptosis, impaired transcription of transition proteins (TNPs) and protamines (PRMs), defective nuclear protein exchange, sperm head deformity, and male infertility.","method":"Bag5 knockout mouse model, IP-mass spectrometry, co-immunoprecipitation, RNA sequencing of knockout testis, western blot","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — IP-MS for interaction plus KO mouse phenotype; single lab with multiple orthogonal methods","pmids":["39992433"],"is_preprint":false},{"year":2024,"finding":"A novel BAG5 frameshift variant (c.444_445delGA) causes DCM by impairing the ER stress response. Bag5-/- knock-in mice show reduced cardiac function and increased apoptosis following tunicamycin (ER stress) challenge, demonstrating BAG5 is required for normal ER stress response in the heart.","method":"Human exome/Sanger sequencing, knock-in mouse model, tunicamycin challenge, echocardiography, apoptosis assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human mutation plus KO mouse stress challenge with defined cardiac phenotype; single lab","pmids":["38796549"],"is_preprint":false},{"year":2026,"finding":"BAG5 interacts with HSPA1A (identified by immunoprecipitation-mass spectrometry). The HSPA1A-BAG5 complex promotes ubiquitination-mediated degradation of ATF2, subsequently downregulating apoptotic signaling in spermatogenic cells.","method":"Co-immunoprecipitation-mass spectrometry, co-immunoprecipitation validation, ubiquitination assay, overexpression/knockdown in spermatogonia/spermatocytes","journal":"Tissue & cell","confidence":"Low","confidence_rationale":"Tier 3 / Weak — IP-MS with co-IP validation and functional assay; single lab, limited independent replication","pmids":["41558067"],"is_preprint":false}],"current_model":"BAG5 is a multi-BAG-domain co-chaperone that functions as a nucleotide exchange factor for Hsp70/HSC70 family members (promoting ADP release and substrate refolding via conformational changes in the Hsp70 NBD), while simultaneously inhibiting the E3 ubiquitin ligase activities of Parkin, CHIP, and MDM2 toward substrates including alpha-synuclein, PTEN, and mutant p53; it localizes to junctional membrane complexes in cardiomyocytes and to the ER under stress, directly interacts with PINK1, DJ-1, GRP78, p62, and Akt to modulate mitophagy, ER stress responses, and protein stability, and is essential for spermatid development through HSPA2/HSPA8-dependent folding of structural proteins required for sperm head-tail coupling apparatus assembly."},"narrative":{"mechanistic_narrative":"BAG5 is a multi-BAG-domain co-chaperone that couples Hsp70/HSC70 chaperone cycling to the control of protein stability and quality-control E3 ligase activity across neuronal, cardiac, tumor, and germ-cell contexts [PMID:15603737, PMID:20223214]. Its fifth BAG domain (BD5) binds the Hsp70 nucleotide-binding domain and triggers conformational changes that disrupt the nucleotide-binding groove, lowering ADP affinity and accelerating Hsp70-mediated refolding — establishing BAG5 as a nucleotide exchange factor [PMID:20223214], an activity it likewise exerts on HSC70 to drive substrate folding [PMID:35044787]. A recurrent theme is that BAG5 restrains E3 ubiquitin ligases: it inhibits Parkin and CHIP and antagonizes MDM2, thereby stabilizing substrates including alpha-synuclein, PTEN, and mutant p53 [PMID:15603737, PMID:21358815, PMID:24148769, PMID:27807478]. In Parkinson-relevant models BAG5 sequesters Parkin in aggregates, enhances dopaminergic neuron death, and impairs Parkin-dependent mitophagy while promoting alpha-synuclein oligomerization [PMID:15603737, PMID:31787745, PMID:21358815]; in cancer it stabilizes gain-of-function mutant p53 to promote proliferation and chemoresistance [PMID:27807478]. BAG5 also acts at the ER, binding GRP78/BiP and modulating the unfolded protein response, and relocalizes to the ER under stress [PMID:23448667]. Loss-of-function mutations in BAG5 cause inherited dilated cardiomyopathy, where BAG5 localizes to cardiomyocyte junctional membrane complexes and its NEF activity toward HSC70 maintains JMC structure and calcium handling, with AAV9-delivered wild-type BAG5 rescuing the phenotype in mice [PMID:35044787, PMID:38796549]. In the male germline BAG5 partners with HSPA8 and HSPA2 to fold structural substrates such as SPATA6 required for sperm head-tail coupling, and its loss causes acephalic spermatozoa and male infertility [PMID:38454159, PMID:39992433].","teleology":[{"year":2004,"claim":"Established BAG5 as a dual-action regulator that simultaneously suppresses Parkin E3 ligase activity and Hsp70 refolding, linking it to dopaminergic neurodegeneration.","evidence":"Co-IP, in vitro ubiquitin ligase assay, and in vivo dopamine neuron loss model with dominant-negative rescue","pmids":["15603737"],"confidence":"High","gaps":["Did not resolve which BAG domain mediates Parkin versus Hsp70 binding","Structural basis of Hsp70 inhibition not defined"]},{"year":2010,"claim":"Defined the molecular mechanism of BAG5 action on Hsp70, showing BD5 acts as a nucleotide exchange factor by remodeling the NBD to release ADP.","evidence":"Crystal structure of BD5-NBD complex with ADP-affinity and in vitro refolding assays","pmids":["20223214"],"confidence":"High","gaps":["Roles of the other four BAG domains in chaperone modulation not structurally resolved","How NEF activity relates to inhibition of refolding seen earlier unclear"]},{"year":2010,"claim":"Extended the Parkin connection by showing BAG5 binds Parkin through all four BAG domains and stabilizes Parkin against proteasomal degradation.","evidence":"GST pulldown, co-IP, cycloheximide chase/ubiquitination assay","pmids":["21131737"],"confidence":"Low","gaps":["Single lab with limited methodological detail","Reconciliation with Parkin sequestration/inhibition model not addressed"]},{"year":2011,"claim":"Showed BAG5 inhibits a second E3 ligase, CHIP, toward alpha-synuclein, generalizing its role as an antagonist of chaperone-associated ubiquitination.","evidence":"Co-IP from brain, in vitro ubiquitinylation assay, luciferase complementation oligomerization assay","pmids":["21358815"],"confidence":"High","gaps":["Whether increased oligomerization is toxic in vivo not established here","Stoichiometry of the BAG5-CHIP-Hsp70-synuclein complex undefined"]},{"year":2013,"claim":"Identified an ER-resident function: BAG5 binds GRP78/BiP, modulates UPR branches, and relocalizes to the ER under stress to suppress apoptosis.","evidence":"Co-IP, ATPase assay, subcellular fractionation, knockdown/overexpression apoptosis readouts","pmids":["23448667"],"confidence":"Medium","gaps":["Mechanism of stress-triggered ER relocalization unknown","How BAG5 differentially tunes PERK versus IRE1 arms not resolved"]},{"year":2013,"claim":"Linked BAG5's CHIP inhibition to PTEN stabilization, broadening its substrate range.","evidence":"Co-IP, ubiquitination assay, western blot","pmids":["24148769"],"confidence":"Low","gaps":["Mechanistic inference from CHIP inhibition with limited orthogonal validation","Physiological context of PTEN regulation not defined"]},{"year":2014,"claim":"Showed BAG5 stabilizes PINK1 by reducing its ubiquitination, protecting against mitochondrial toxin damage and tying BAG5 into mitochondrial quality control.","evidence":"Yeast two-hybrid, GST pulldown, co-IP, ubiquitination assay, toxin viability assay","pmids":["24475098"],"confidence":"Medium","gaps":["Reconciliation with later mitophagy-impairing role not addressed","E3 ligase acting on PINK1 not identified"]},{"year":2014,"claim":"Added polyQ disease context by showing BAG5 (with BAG2) stabilizes pathogenic ataxin3-80Q.","evidence":"Co-immunofluorescence, western blot, ubiquitination assay","pmids":["25006867"],"confidence":"Low","gaps":["No direct binding assay described","Single lab, limited mechanistic detail"]},{"year":2016,"claim":"Demonstrated an oncogenic role: BAG5 protects mutant p53 from MDM2- and CHIP-mediated degradation, enabling gain-of-function tumor phenotypes.","evidence":"Co-IP, ubiquitination assay, proliferation/migration/tumor growth assays","pmids":["27807478"],"confidence":"Medium","gaps":["Selectivity for mutant versus wild-type p53 mechanism unclear","In vivo tumor dependence on BAG5 not fully delineated"]},{"year":2017,"claim":"Reported BAG5 destabilizes DJ-1 and weakens its mitochondrial protection, a directionally distinct effect from its substrate-stabilizing roles.","evidence":"Co-IP, immunofluorescence, western blot","pmids":["28348719"],"confidence":"Low","gaps":["Effect on DJ-1 dimerization not directly demonstrated","Mechanism of destabilization undefined"]},{"year":2019,"claim":"Resolved BAG5's role in mitophagy, showing it suppresses Parkin recruitment to damaged mitochondria while enhancing Parkin-mediated Mcl-1 degradation and death, revealing bimodal control.","evidence":"Live-cell mitochondrial recruitment imaging, lysosomal colocalization, cell death and Mcl-1 degradation assays","pmids":["31787745"],"confidence":"Medium","gaps":["Molecular switch governing the bimodal outcome unknown","Relationship to PINK1 stabilization not integrated"]},{"year":2020,"claim":"Connected BAG5 to autophagy machinery via p62/SQSTM1 interaction and showed it promotes pathogenic alpha-synuclein oligomers.","evidence":"Co-IP, oligomerization assay, subcellular fractionation/immunofluorescence","pmids":["32850835"],"confidence":"Medium","gaps":["Whether p62 binding alters autophagic flux not quantified","Direct versus indirect effect on oligomerization unresolved"]},{"year":2020,"claim":"Placed BAG5 downstream of p53 transcriptionally, showing stress-induced p53 binds the BAG5 promoter and BAG5 is required for alpha-synuclein aggregation.","evidence":"ChIP, co-IP from PD patient brain lysates, siRNA knockdown aggregation assay","pmids":["33085644"],"confidence":"Medium","gaps":["Feedback between p53-induced BAG5 and BAG5's stabilization of mutant p53 not explored","In vivo relevance of the axis untested"]},{"year":2020,"claim":"Identified PRMT6 methylation of BAG5 as a post-translational switch controlling HSC70 stability, autophagy, and hepatocellular tumorigenicity.","evidence":"Co-IP, methylation assay, BAG5 knockdown with in vivo tumor model","pmids":["33186656"],"confidence":"Medium","gaps":["Methylated residues and their effect on NEF activity not mapped","Generality beyond HCC unknown"]},{"year":2020,"claim":"Reported a translational-regulatory function in thyroid cancer, with BAG5 modulating FN1 via miR-144-3p to promote invasion.","evidence":"Overexpression/knockdown, polysome fractionation, invasion assay, miR-144-3p functional assay","pmids":["32275930"],"confidence":"Low","gaps":["Mechanistic link between BAG5 and miRNA suppression unclear","Limited detail and single lab"]},{"year":2022,"claim":"Established BAG5 as a disease gene for inherited dilated cardiomyopathy and defined its cardiac mechanism as HSC70 NEF activity supporting junctional membrane complex structure and calcium handling.","evidence":"Human genetics, knock-in mouse phenocopy, JMC localization, calcium assays, AAV9 gene rescue","pmids":["35044787"],"confidence":"High","gaps":["Identity of the structural folding substrates at the JMC not defined","Why cardiac tissue is selectively vulnerable unclear"]},{"year":2023,"claim":"Showed BAG5 regulates Akt stability by switching Akt from mono- to polyubiquitination, with the complex governed by phosphorylation and growth-factor signaling.","evidence":"Co-IP, domain mapping, ubiquitination switch assay, knockdown/overexpression Akt stability readouts","pmids":["38139359"],"confidence":"Medium","gaps":["E3 ligase mediating the ubiquitination switch not identified","Physiological signaling outcomes of Akt regulation untested"]},{"year":2024,"claim":"Defined an essential germ-cell role: BAG5 partners HSPA8 to fold SPATA6 and other structural proteins, and its loss causes acephalic spermatozoa and infertility.","evidence":"BAG5 knockout mouse, co-IP, in vitro chaperone substrate-affinity assay, spermatid immunofluorescence","pmids":["38454159"],"confidence":"High","gaps":["How BAG5 selects this specific substrate set is unknown","Whether NEF activity alone accounts for folding enhancement unresolved"]},{"year":2024,"claim":"Provided a second human DCM variant and tied cardiac dysfunction to an impaired ER stress response in vivo.","evidence":"Human exome/Sanger sequencing, knock-in mouse with tunicamycin challenge, echocardiography, apoptosis assay","pmids":["38796549"],"confidence":"Medium","gaps":["Relationship between ER stress defect and JMC/calcium phenotype not integrated","Causal UPR branch in the heart not pinpointed"]},{"year":2025,"claim":"Extended germline function to earlier stages, showing BAG5 stabilizes HSPA2 in spermatocytes to support nuclear protein exchange and prevent germ cell apoptosis.","evidence":"Bag5 knockout mouse, IP-mass spectrometry, co-IP, testis RNA-seq, western blot","pmids":["39992433"],"confidence":"Medium","gaps":["Direct chaperone substrates of the BAG5-HSPA2 complex not defined","Mechanism linking HSPA2 loss to TNP/PRM transcription unclear"]},{"year":2026,"claim":"Reported BAG5 partnering with HSPA1A to promote ATF2 degradation and dampen apoptotic signaling in spermatogenic cells.","evidence":"Co-IP-mass spectrometry, co-IP validation, ubiquitination assay, overexpression/knockdown","pmids":["41558067"],"confidence":"Low","gaps":["Single lab with limited independent replication","E3 ligase mediating ATF2 degradation not identified"]},{"year":null,"claim":"It remains unresolved how a single BAG5 NEF/co-chaperone activity is mechanistically partitioned to produce opposite outcomes — substrate stabilization versus destabilization, mitochondrial protection versus mitophagy suppression — across its different tissue and substrate contexts.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying structural/biophysical model linking the four BAG domains plus BD5 to context-specific outcomes","Determinants of substrate selection across neurons, heart, germline, and tumor cells unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,7,13]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[1,13,15]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,7,16]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3,19]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,13,15]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[3,19]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[9,10]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,3,9]}],"complexes":["BAG5-Hsp70-Parkin complex","BAG5-CHIP-Hsp70-alpha-synuclein complex","BAG5-HSPA8 complex","junctional membrane complex (cardiomyocyte)"],"partners":["HSPA8","PARKIN","CHIP","PINK1","GRP78","P62","HSPA2","AKT"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UL15","full_name":"BAG family molecular chaperone regulator 5","aliases":["Bcl-2-associated athanogene 5"],"length_aa":447,"mass_kda":51.2,"function":"Co-chaperone for HSP/HSP70 proteins. It functions as a nucleotide-exchange factor promoting the release of ADP from HSP70, thereby activating HSP70-mediated protein refolding (PubMed:20223214). Has an essential role in maintaining proteostasis at junctional membrane complexes (JMC), where it may function as a scaffold between the HSPA8 chaperone and JMC proteins enabling correct, HSPA8-dependent JMC protein folding (By similarity). Inhibits both auto-ubiquitination of PRKN and ubiquitination of target proteins by PRKN (By similarity)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q9UL15/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BAG5","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DNAJC7","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/search/BAG5","total_profiled":1310},"omim":[{"mim_id":"619747","title":"CARDIOMYOPATHY, DILATED, 2F; CMD2F","url":"https://www.omim.org/entry/619747"},{"mim_id":"603885","title":"BAG COCHAPERONE 5; BAG5","url":"https://www.omim.org/entry/603885"},{"mim_id":"603882","title":"BAG COCHAPERONE 2; BAG2","url":"https://www.omim.org/entry/603882"},{"mim_id":"602861","title":"PLAKOPHILIN 2; PKP2","url":"https://www.omim.org/entry/602861"},{"mim_id":"602544","title":"PARKIN RBR E3 UBIQUITIN PROTEIN LIGASE; PRKN","url":"https://www.omim.org/entry/602544"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"},{"location":"Primary cilium tip","reliability":"Additional"},{"location":"Centrosome","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"testis","ntpm":119.4}],"url":"https://www.proteinatlas.org/search/BAG5"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9UL15","domains":[{"cath_id":"1.20.58.120","chopping":"7-87","consensus_level":"medium","plddt":95.0504,"start":7,"end":87},{"cath_id":"1.20.58.120","chopping":"273-441","consensus_level":"medium","plddt":92.817,"start":273,"end":441},{"cath_id":"1.20.140","chopping":"89-261","consensus_level":"medium","plddt":88.2037,"start":89,"end":261}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UL15","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UL15-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UL15-F1-predicted_aligned_error_v6.png","plddt_mean":90.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BAG5","jax_strain_url":"https://www.jax.org/strain/search?query=BAG5"},"sequence":{"accession":"Q9UL15","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UL15.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UL15/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UL15"}},"corpus_meta":[{"pmid":"15603737","id":"PMC_15603737","title":"BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.","date":"2004","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/15603737","citation_count":173,"is_preprint":false},{"pmid":"21358815","id":"PMC_21358815","title":"Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5).","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21358815","citation_count":124,"is_preprint":false},{"pmid":"8604117","id":"PMC_8604117","title":"An immunohistochemical method for detecting bradyzoite antigen (BAG5) in Toxoplasma gondii-infected tissues cross-reacts with a Neospora caninum bradyzoite antigen.","date":"1996","source":"The Journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/8604117","citation_count":111,"is_preprint":false},{"pmid":"20223214","id":"PMC_20223214","title":"The C-terminal BAG domain of BAG5 induces conformational changes of the Hsp70 nucleotide-binding domain for ADP-ATP exchange.","date":"2010","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/20223214","citation_count":73,"is_preprint":false},{"pmid":"27539741","id":"PMC_27539741","title":"CaM/BAG5/Hsc70 signaling complex dynamically regulates leaf senescence.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27539741","citation_count":53,"is_preprint":false},{"pmid":"23448667","id":"PMC_23448667","title":"Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.","date":"2013","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23448667","citation_count":51,"is_preprint":false},{"pmid":"26729625","id":"PMC_26729625","title":"GRP78 Interacting Partner Bag5 Responds to ER Stress and Protects Cardiomyocytes From ER Stress-Induced Apoptosis.","date":"2016","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26729625","citation_count":51,"is_preprint":false},{"pmid":"24475098","id":"PMC_24475098","title":"BAG5 protects against mitochondrial oxidative damage through regulating PINK1 degradation.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24475098","citation_count":48,"is_preprint":false},{"pmid":"27571744","id":"PMC_27571744","title":"MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27571744","citation_count":44,"is_preprint":false},{"pmid":"31787745","id":"PMC_31787745","title":"Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31787745","citation_count":40,"is_preprint":false},{"pmid":"31948758","id":"PMC_31948758","title":"miR-155 inhibits mitophagy through suppression of BAG5, a partner protein of PINK1.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31948758","citation_count":31,"is_preprint":false},{"pmid":"27807478","id":"PMC_27807478","title":"A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis.","date":"2016","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/27807478","citation_count":28,"is_preprint":false},{"pmid":"33186656","id":"PMC_33186656","title":"PRMT6 deficiency induces autophagy in hostile microenvironments of hepatocellular carcinoma tumors by regulating BAG5-associated HSC70 stability.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/33186656","citation_count":28,"is_preprint":false},{"pmid":"28348719","id":"PMC_28348719","title":"BAG5 Interacts with DJ-1 and Inhibits the Neuroprotective Effects of DJ-1 to Combat Mitochondrial Oxidative Damage.","date":"2017","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/28348719","citation_count":26,"is_preprint":false},{"pmid":"15603730","id":"PMC_15603730","title":"Parkin and Hsp70 sacked by BAG5.","date":"2004","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/15603730","citation_count":23,"is_preprint":false},{"pmid":"32275930","id":"PMC_32275930","title":"BAG5 promotes invasion of papillary thyroid cancer cells via upregulation of fibronectin 1 at the translational level.","date":"2020","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32275930","citation_count":20,"is_preprint":false},{"pmid":"35044787","id":"PMC_35044787","title":"Loss-of-function mutations in the co-chaperone protein BAG5 cause dilated cardiomyopathy requiring heart transplantation.","date":"2022","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35044787","citation_count":20,"is_preprint":false},{"pmid":"31922242","id":"PMC_31922242","title":"miR‑155 inhibition represents a potential valuable regulator in mitigating myocardial hypoxia/reoxygenation injury through targeting BAG5 and MAPK/JNK signaling.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/31922242","citation_count":20,"is_preprint":false},{"pmid":"11909735","id":"PMC_11909735","title":"Toxoplasma gondii: in vivo expression of BAG-5 and cyst formation is independent of TNF p55 receptor and inducible nitric oxide synthase functions.","date":"2002","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/11909735","citation_count":20,"is_preprint":false},{"pmid":"33481351","id":"PMC_33481351","title":"Circ_0008305-mediated miR-660/BAG5 axis contributes to hepatocellular carcinoma tumorigenesis.","date":"2021","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33481351","citation_count":16,"is_preprint":false},{"pmid":"38454159","id":"PMC_38454159","title":"BAG5 regulates HSPA8-mediated protein folding required for sperm head-tail coupling apparatus assembly.","date":"2024","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/38454159","citation_count":15,"is_preprint":false},{"pmid":"33085644","id":"PMC_33085644","title":"Stress-induced p53 drives BAG5 cochaperone expression to control α-synuclein aggregation in Parkinson's disease.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33085644","citation_count":15,"is_preprint":false},{"pmid":"25367796","id":"PMC_25367796","title":"Bag5 protects neuronal cells from amyloid β-induced cell death.","date":"2014","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/25367796","citation_count":14,"is_preprint":false},{"pmid":"24148769","id":"PMC_24148769","title":"BAG5 regulates PTEN stability in MCF-7 cell line.","date":"2013","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/24148769","citation_count":14,"is_preprint":false},{"pmid":"23146300","id":"PMC_23146300","title":"Protective effect of BAG5 on MPP+-induced apoptosis in PC12 cells.","date":"2012","source":"Neurological research","url":"https://pubmed.ncbi.nlm.nih.gov/23146300","citation_count":13,"is_preprint":false},{"pmid":"33283947","id":"PMC_33283947","title":"MiRNA-429 alleviates ketamine-induced neurotoxicity through targeting BAG5.","date":"2020","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/33283947","citation_count":12,"is_preprint":false},{"pmid":"25006867","id":"PMC_25006867","title":"The BAG2 and BAG5 proteins inhibit the ubiquitination of pathogenic ataxin3-80Q.","date":"2014","source":"The International journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25006867","citation_count":11,"is_preprint":false},{"pmid":"32850835","id":"PMC_32850835","title":"BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32850835","citation_count":9,"is_preprint":false},{"pmid":"34126157","id":"PMC_34126157","title":"Implication of BAG5 downregulation in metabolic reprogramming of cisplatin-resistant ovarian cancer cells via mTORC2 signaling pathway.","date":"2021","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34126157","citation_count":8,"is_preprint":false},{"pmid":"35821856","id":"PMC_35821856","title":"Role of BAG5 in Protein Quality Control: Double-Edged Sword?","date":"2022","source":"Frontiers in aging","url":"https://pubmed.ncbi.nlm.nih.gov/35821856","citation_count":7,"is_preprint":false},{"pmid":"34707706","id":"PMC_34707706","title":"miR-142-5p regulates lipopolysaccharide-induced bovine epithelial cell proliferation and apoptosis via targeting BAG5.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34707706","citation_count":7,"is_preprint":false},{"pmid":"33137395","id":"PMC_33137395","title":"Identification of BAG5 from orange-spotted grouper (Epinephelus coioides) involved in viral infection.","date":"2020","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33137395","citation_count":6,"is_preprint":false},{"pmid":"33986829","id":"PMC_33986829","title":"miRNA-770-5p expression is upregulated in patients with type 2 diabetes and miRNA-770-5p knockdown protects pancreatic β-cell function via targeting BAG5 expression.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33986829","citation_count":6,"is_preprint":false},{"pmid":"34670429","id":"PMC_34670429","title":"Lipoxin A4 methyl ester protects PC12 cells from ketamine-induced neurotoxicity via the miR-22/BAG5 pathway.","date":"2021","source":"Human & experimental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34670429","citation_count":6,"is_preprint":false},{"pmid":"36151390","id":"PMC_36151390","title":"LncRNA TUG1 Promoted Stabilization of BAG5 by Binding DDX3X to Exacerbate Ketamine-Induced Neurotoxicity.","date":"2022","source":"Neurotoxicity research","url":"https://pubmed.ncbi.nlm.nih.gov/36151390","citation_count":4,"is_preprint":false},{"pmid":"21131737","id":"PMC_21131737","title":"[Direct interaction between BAG5 protein and Parkin protein].","date":"2010","source":"Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21131737","citation_count":3,"is_preprint":false},{"pmid":"38139359","id":"PMC_38139359","title":"Akt Is Controlled by Bag5 through a Monoubiquitination to Polyubiquitination Switch.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38139359","citation_count":3,"is_preprint":false},{"pmid":"35968372","id":"PMC_35968372","title":"Identification of BAG5 as a Potential Biomarker for Parkinson's Disease Patients With R492X PINK1 Mutation.","date":"2022","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35968372","citation_count":2,"is_preprint":false},{"pmid":"39788499","id":"PMC_39788499","title":"Beta-amyloid protein regulates miR-15a and activates Bag5 to influence neuronal apoptosis in Alzheimer's disease.","date":"2024","source":"Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39788499","citation_count":1,"is_preprint":false},{"pmid":"38796549","id":"PMC_38796549","title":"A novel BAG5 variant impairs the ER stress response pathway, causing dilated cardiomyopathy and arrhythmia.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38796549","citation_count":1,"is_preprint":false},{"pmid":"40945824","id":"PMC_40945824","title":"MSTRG.118323.5 targets BAG5 as a miR-200-y sponge to regulate Sertoli cells apoptosis via PI3K/AKT/mTOR pathways of Bactrian camels.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40945824","citation_count":1,"is_preprint":false},{"pmid":"40787462","id":"PMC_40787462","title":"Mechanistic insights into promotion of non-small cell lung cancer by BAG5 using integrative multi-omics approaches.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40787462","citation_count":0,"is_preprint":false},{"pmid":"39992433","id":"PMC_39992433","title":"Male germ cells with Bag5 deficiency show reduced spermiogenesis and exchange of basic nuclear proteins.","date":"2025","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/39992433","citation_count":0,"is_preprint":false},{"pmid":"41558067","id":"PMC_41558067","title":"HSPA1A-BAG5 chaperone complex promotes spermatogenesis by driving ubiquitination-mediated degradation of ATF2.","date":"2026","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/41558067","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23291,"output_tokens":5016,"usd":0.072556,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13253,"output_tokens":5909,"usd":0.106995,"stage2_stop_reason":"end_turn"},"total_usd":0.179551,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"BAG5 directly interacts with parkin and Hsp70. Within this complex, BAG5 inhibits parkin E3 ubiquitin ligase activity and Hsp70-mediated refolding of misfolded proteins. BAG5 enhances parkin sequestration within protein aggregates and mitigates parkin-dependent preservation of proteasome function, enhancing dopamine neuron death in an in vivo PD model.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitin ligase assay, in vivo dopamine neuron loss model, dominant-negative BAG5 mutant rescue\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interactions confirmed, in vitro enzymatic assay, in vivo model with mutant rescue; replicated conceptually by multiple subsequent studies\",\n      \"pmids\": [\"15603737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The fifth BAG domain (BD5) of BAG5 is responsible for interaction with the Hsp70 nucleotide-binding domain (NBD). Crystal structures of the BD5-NBD complex reveal that BD5 binding causes conformational changes in the NBD that disrupt the nucleotide-binding groove, reducing NBD affinity for ADP. BD5 and full-length BAG5 accelerate Hsp70-mediated refolding in vitro, establishing BAG5 as a nucleotide exchange factor (NEF) for Hsp70.\",\n      \"method\": \"Crystal structure determination, in vitro ADP-binding affinity assay, in vitro protein refolding assay\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation (ADP affinity assay + refolding assay), multiple orthogonal methods in one study\",\n      \"pmids\": [\"20223214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BAG5 forms a protein complex with CHIP (E3 ubiquitin ligase) and alpha-synuclein in brain, mediated by Hsp70 binding to CHIP's TPR domain and BAG5's BAG domains. BAG5 inhibits CHIP E3 ubiquitin ligase activity toward alpha-synuclein, reducing alpha-synuclein ubiquitinylation and thereby increasing alpha-synuclein oligomerization.\",\n      \"method\": \"Co-immunoprecipitation from brain tissue, in vitro ubiquitinylation assay, luciferase protein-fragment complementation assay of alpha-synuclein oligomerization\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro ubiquitinylation assay combined with co-IP from brain and live-cell oligomerization assay; multiple orthogonal methods in single lab\",\n      \"pmids\": [\"21358815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BAG5 interacts with the ER-resident chaperone GRP78/BiP and enhances its ATPase activity. During ER stress, BAG5 relocates from the cytoplasm to the ER and inhibits ER-stress-induced apoptosis by suppressing the PERK-eIF2-ATF4 axis while enhancing the IRE1-Xbp1 axis of the unfolded protein response.\",\n      \"method\": \"Co-immunoprecipitation, ATPase activity assay, subcellular fractionation/relocalization, siRNA knockdown and overexpression with apoptosis readouts\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus ATPase assay plus pathway analysis; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"23448667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BAG5 directly interacts with PINK1, stabilizes PINK1 by decreasing its ubiquitination, and thereby protects against mitochondrial dysfunction induced by MPP+ and rotenone.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, ubiquitination assay, cell viability assay with mitochondrial toxins\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid and pulldown for interaction, ubiquitination assay for mechanism; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"24475098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BAG5, as an inhibitor of CHIP E3 ubiquitin ligase activity, reduces CHIP-mediated ubiquitination and degradation of PTEN, thereby maintaining PTEN protein levels via a ubiquitylation-dependent pathway.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, western blot\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, mechanistic inference from CHIP inhibition; limited orthogonal validation\",\n      \"pmids\": [\"24148769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BAG2 and BAG5 stabilize pathogenic ataxin3-80Q by inhibiting its ubiquitination, as shown by co-immunofluorescence and western blotting experiments.\",\n      \"method\": \"Co-immunofluorescence, western blotting, ubiquitination assay\",\n      \"journal\": \"The International journal of neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, limited mechanistic detail in abstract, no direct binding assay described\",\n      \"pmids\": [\"25006867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BAG5 interacts with mutant p53 (mutp53) proteins and protects mutp53 from ubiquitination and degradation by E3 ubiquitin ligases MDM2 and CHIP, leading to mutp53 accumulation and gain-of-function activities including increased cell proliferation, tumor growth, cell migration, and chemoresistance.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, siRNA knockdown and overexpression with proliferation/migration/tumor growth assays\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus ubiquitination assay plus functional readouts; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"27807478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BAG5 interacts with DJ-1 in mammalian cells, decreases DJ-1 stability, and weakens DJ-1's role in mitochondrial protection, possibly by influencing DJ-1 dimerization under stress conditions.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, western blot\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, co-IP and immunofluorescence only, mechanism of dimerization effect not directly demonstrated\",\n      \"pmids\": [\"28348719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BAG5 impairs Parkin-dependent mitophagy by suppressing Parkin recruitment to damaged mitochondria and reducing movement of damaged mitochondria into lysosomes. BAG5 also enhances Parkin-mediated Mcl-1 degradation and cell death following severe mitochondrial insult, suggesting BAG5 regulates the bi-modal activity of Parkin.\",\n      \"method\": \"Live-cell imaging of mitochondrial recruitment, lysosomal colocalization assay, cell death assays, Mcl-1 degradation assay\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization imaging with functional consequence, multiple cellular assays; single lab\",\n      \"pmids\": [\"31787745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BAG5 interacts with p62/SQSTM1, enhances formation of pathogenic alpha-synuclein oligomers, and regulates the levels and subcellular distribution of p62, bridging the chaperone network to autophagy-mediated protein degradation.\",\n      \"method\": \"Co-immunoprecipitation, alpha-synuclein oligomerization assay, subcellular fractionation/immunofluorescence\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP plus oligomerization assay plus localization data; single lab, multiple methods\",\n      \"pmids\": [\"32850835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Stress-induced p53 binds directly to the BAG5 promoter to stimulate BAG5 expression. Induced BAG5 binds alpha-synuclein and Hsp70 in cell cultures and PD patient brain lysates, and BAG5 expression is required for alpha-synuclein aggregation in SH-SY5Y cells.\",\n      \"method\": \"ChIP assay (p53 binding to BAG5 promoter), co-immunoprecipitation from brain lysates, siRNA knockdown with aggregation readout\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct promoter binding, co-IP from patient brain lysates, loss-of-function aggregation assay; single lab\",\n      \"pmids\": [\"33085644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PRMT6 physically interacts with and methylates BAG5, and this methylation enhances degradation of BAG5's binding partner HSC70. PRMT6 deficiency leads to increased BAG5-associated HSC70 stability, promoting autophagy and tumorigenicity in hepatocellular carcinoma.\",\n      \"method\": \"Co-immunoprecipitation, methylation assay, genetic knockdown of BAG5 with in vivo tumor model\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus post-translational modification assay plus in vivo rescue; single lab\",\n      \"pmids\": [\"33186656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Loss-of-function mutations in BAG5 cause inherited dilated cardiomyopathy. BAG5 acts as a nucleotide exchange factor for HSC70, promoting ADP release and activating HSC70-mediated protein folding. BAG5 localizes to junctional membrane complexes (JMCs) in cardiomyocytes; its loss disrupts JMC structure and calcium handling. AAV9-mediated wild-type BAG5 gene delivery fully rescues the DCM phenotype in knock-in mice.\",\n      \"method\": \"Human genetics (homozygous truncating mutations), knock-in mouse model, immunocytochemistry for JMC localization, calcium handling assays, AAV9 gene rescue\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — human genetics with complete penetrance, knock-in mouse phenocopying, localization with functional consequence, gene rescue; multiple orthogonal methods across labs\",\n      \"pmids\": [\"35044787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BAG5 modulates fibronectin 1 (FN1) expression at the translational level in papillary thyroid cancer cells, promoting invasion via suppression of miR-144-3p, which targets the 3' UTR of FN1 transcript.\",\n      \"method\": \"BAG5 overexpression/knockdown, western blot and polysome fractionation for translational regulation, invasion assay, miR-144-3p functional assay\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mechanistic details on translational regulation are limited in abstract; single lab\",\n      \"pmids\": [\"32275930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BAG5 forms a complex with HSPA8 in spermatids and promotes folding of SPATA6 (a sperm head-tail coupling apparatus component) by enhancing HSPA8's affinity for substrate proteins. BAG5-deficient male mice show misfolded SPATA6, MYO5A, MYL6, DYNLT1, DCTN1, and DNAL1, leading to aberrant HTCA assembly, acephalic spermatozoa syndrome, and male infertility.\",\n      \"method\": \"BAG5 knockout mouse model, co-immunoprecipitation, in vitro chaperone substrate-affinity assay, immunofluorescence of spermatid assembly\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — KO mouse with defined phenotype, co-IP, in vitro chaperone assay demonstrating mechanism; multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"38454159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BAG5 interacts with Akt at the linker region between its first and second BAG domains, and Akt phosphorylates BAG5's first BAG domain. BAG5 switches Akt from monoubiquitination to polyubiquitination (together with Hsp70), promoting Akt degradation. The BAG5-Akt complex forms under serum-starved conditions and dissociates upon HGF stimulation, coincident with BAG5 phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, BAG5 knockdown/overexpression with Akt stability readouts, deletion mapping of interaction domain\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mapping, ubiquitination switch assay, loss/gain of function; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38139359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BAG5 directly interacts with Parkin through all four BAG domains and stabilizes Parkin protein by interfering with its degradation via the ubiquitin-mediated proteasomal pathway.\",\n      \"method\": \"GST pulldown, co-immunoprecipitation, cycloheximide chase/ubiquitination assay\",\n      \"journal\": \"Zhong nan da xue xue bao. Yi xue ban\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pulldown and co-IP with chase experiment; single lab, limited methodological detail in abstract\",\n      \"pmids\": [\"21131737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BAG5 interacts with HSPA2 (testis-specific HSP70 family member) in spermatocytes. BAG5 deficiency reduces HSPA2 levels, leading to germ cell apoptosis, impaired transcription of transition proteins (TNPs) and protamines (PRMs), defective nuclear protein exchange, sperm head deformity, and male infertility.\",\n      \"method\": \"Bag5 knockout mouse model, IP-mass spectrometry, co-immunoprecipitation, RNA sequencing of knockout testis, western blot\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — IP-MS for interaction plus KO mouse phenotype; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"39992433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A novel BAG5 frameshift variant (c.444_445delGA) causes DCM by impairing the ER stress response. Bag5-/- knock-in mice show reduced cardiac function and increased apoptosis following tunicamycin (ER stress) challenge, demonstrating BAG5 is required for normal ER stress response in the heart.\",\n      \"method\": \"Human exome/Sanger sequencing, knock-in mouse model, tunicamycin challenge, echocardiography, apoptosis assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human mutation plus KO mouse stress challenge with defined cardiac phenotype; single lab\",\n      \"pmids\": [\"38796549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"BAG5 interacts with HSPA1A (identified by immunoprecipitation-mass spectrometry). The HSPA1A-BAG5 complex promotes ubiquitination-mediated degradation of ATF2, subsequently downregulating apoptotic signaling in spermatogenic cells.\",\n      \"method\": \"Co-immunoprecipitation-mass spectrometry, co-immunoprecipitation validation, ubiquitination assay, overexpression/knockdown in spermatogonia/spermatocytes\",\n      \"journal\": \"Tissue & cell\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — IP-MS with co-IP validation and functional assay; single lab, limited independent replication\",\n      \"pmids\": [\"41558067\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BAG5 is a multi-BAG-domain co-chaperone that functions as a nucleotide exchange factor for Hsp70/HSC70 family members (promoting ADP release and substrate refolding via conformational changes in the Hsp70 NBD), while simultaneously inhibiting the E3 ubiquitin ligase activities of Parkin, CHIP, and MDM2 toward substrates including alpha-synuclein, PTEN, and mutant p53; it localizes to junctional membrane complexes in cardiomyocytes and to the ER under stress, directly interacts with PINK1, DJ-1, GRP78, p62, and Akt to modulate mitophagy, ER stress responses, and protein stability, and is essential for spermatid development through HSPA2/HSPA8-dependent folding of structural proteins required for sperm head-tail coupling apparatus assembly.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BAG5 is a multi-BAG-domain co-chaperone that couples Hsp70/HSC70 chaperone cycling to the control of protein stability and quality-control E3 ligase activity across neuronal, cardiac, tumor, and germ-cell contexts [#0, #1]. Its fifth BAG domain (BD5) binds the Hsp70 nucleotide-binding domain and triggers conformational changes that disrupt the nucleotide-binding groove, lowering ADP affinity and accelerating Hsp70-mediated refolding — establishing BAG5 as a nucleotide exchange factor [#1], an activity it likewise exerts on HSC70 to drive substrate folding [#13]. A recurrent theme is that BAG5 restrains E3 ubiquitin ligases: it inhibits Parkin and CHIP and antagonizes MDM2, thereby stabilizing substrates including alpha-synuclein, PTEN, and mutant p53 [#0, #2, #5, #7]. In Parkinson-relevant models BAG5 sequesters Parkin in aggregates, enhances dopaminergic neuron death, and impairs Parkin-dependent mitophagy while promoting alpha-synuclein oligomerization [#0, #9, #2]; in cancer it stabilizes gain-of-function mutant p53 to promote proliferation and chemoresistance [#7]. BAG5 also acts at the ER, binding GRP78/BiP and modulating the unfolded protein response, and relocalizes to the ER under stress [#3]. Loss-of-function mutations in BAG5 cause inherited dilated cardiomyopathy, where BAG5 localizes to cardiomyocyte junctional membrane complexes and its NEF activity toward HSC70 maintains JMC structure and calcium handling, with AAV9-delivered wild-type BAG5 rescuing the phenotype in mice [#13, #19]. In the male germline BAG5 partners with HSPA8 and HSPA2 to fold structural substrates such as SPATA6 required for sperm head-tail coupling, and its loss causes acephalic spermatozoa and male infertility [#15, #18].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established BAG5 as a dual-action regulator that simultaneously suppresses Parkin E3 ligase activity and Hsp70 refolding, linking it to dopaminergic neurodegeneration.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitin ligase assay, and in vivo dopamine neuron loss model with dominant-negative rescue\",\n      \"pmids\": [\"15603737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which BAG domain mediates Parkin versus Hsp70 binding\", \"Structural basis of Hsp70 inhibition not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined the molecular mechanism of BAG5 action on Hsp70, showing BD5 acts as a nucleotide exchange factor by remodeling the NBD to release ADP.\",\n      \"evidence\": \"Crystal structure of BD5-NBD complex with ADP-affinity and in vitro refolding assays\",\n      \"pmids\": [\"20223214\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Roles of the other four BAG domains in chaperone modulation not structurally resolved\", \"How NEF activity relates to inhibition of refolding seen earlier unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extended the Parkin connection by showing BAG5 binds Parkin through all four BAG domains and stabilizes Parkin against proteasomal degradation.\",\n      \"evidence\": \"GST pulldown, co-IP, cycloheximide chase/ubiquitination assay\",\n      \"pmids\": [\"21131737\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single lab with limited methodological detail\", \"Reconciliation with Parkin sequestration/inhibition model not addressed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed BAG5 inhibits a second E3 ligase, CHIP, toward alpha-synuclein, generalizing its role as an antagonist of chaperone-associated ubiquitination.\",\n      \"evidence\": \"Co-IP from brain, in vitro ubiquitinylation assay, luciferase complementation oligomerization assay\",\n      \"pmids\": [\"21358815\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether increased oligomerization is toxic in vivo not established here\", \"Stoichiometry of the BAG5-CHIP-Hsp70-synuclein complex undefined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified an ER-resident function: BAG5 binds GRP78/BiP, modulates UPR branches, and relocalizes to the ER under stress to suppress apoptosis.\",\n      \"evidence\": \"Co-IP, ATPase assay, subcellular fractionation, knockdown/overexpression apoptosis readouts\",\n      \"pmids\": [\"23448667\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of stress-triggered ER relocalization unknown\", \"How BAG5 differentially tunes PERK versus IRE1 arms not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Linked BAG5's CHIP inhibition to PTEN stabilization, broadening its substrate range.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, western blot\",\n      \"pmids\": [\"24148769\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanistic inference from CHIP inhibition with limited orthogonal validation\", \"Physiological context of PTEN regulation not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed BAG5 stabilizes PINK1 by reducing its ubiquitination, protecting against mitochondrial toxin damage and tying BAG5 into mitochondrial quality control.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, co-IP, ubiquitination assay, toxin viability assay\",\n      \"pmids\": [\"24475098\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reconciliation with later mitophagy-impairing role not addressed\", \"E3 ligase acting on PINK1 not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Added polyQ disease context by showing BAG5 (with BAG2) stabilizes pathogenic ataxin3-80Q.\",\n      \"evidence\": \"Co-immunofluorescence, western blot, ubiquitination assay\",\n      \"pmids\": [\"25006867\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct binding assay described\", \"Single lab, limited mechanistic detail\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated an oncogenic role: BAG5 protects mutant p53 from MDM2- and CHIP-mediated degradation, enabling gain-of-function tumor phenotypes.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, proliferation/migration/tumor growth assays\",\n      \"pmids\": [\"27807478\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Selectivity for mutant versus wild-type p53 mechanism unclear\", \"In vivo tumor dependence on BAG5 not fully delineated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Reported BAG5 destabilizes DJ-1 and weakens its mitochondrial protection, a directionally distinct effect from its substrate-stabilizing roles.\",\n      \"evidence\": \"Co-IP, immunofluorescence, western blot\",\n      \"pmids\": [\"28348719\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Effect on DJ-1 dimerization not directly demonstrated\", \"Mechanism of destabilization undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved BAG5's role in mitophagy, showing it suppresses Parkin recruitment to damaged mitochondria while enhancing Parkin-mediated Mcl-1 degradation and death, revealing bimodal control.\",\n      \"evidence\": \"Live-cell mitochondrial recruitment imaging, lysosomal colocalization, cell death and Mcl-1 degradation assays\",\n      \"pmids\": [\"31787745\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular switch governing the bimodal outcome unknown\", \"Relationship to PINK1 stabilization not integrated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Connected BAG5 to autophagy machinery via p62/SQSTM1 interaction and showed it promotes pathogenic alpha-synuclein oligomers.\",\n      \"evidence\": \"Co-IP, oligomerization assay, subcellular fractionation/immunofluorescence\",\n      \"pmids\": [\"32850835\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether p62 binding alters autophagic flux not quantified\", \"Direct versus indirect effect on oligomerization unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed BAG5 downstream of p53 transcriptionally, showing stress-induced p53 binds the BAG5 promoter and BAG5 is required for alpha-synuclein aggregation.\",\n      \"evidence\": \"ChIP, co-IP from PD patient brain lysates, siRNA knockdown aggregation assay\",\n      \"pmids\": [\"33085644\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Feedback between p53-induced BAG5 and BAG5's stabilization of mutant p53 not explored\", \"In vivo relevance of the axis untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified PRMT6 methylation of BAG5 as a post-translational switch controlling HSC70 stability, autophagy, and hepatocellular tumorigenicity.\",\n      \"evidence\": \"Co-IP, methylation assay, BAG5 knockdown with in vivo tumor model\",\n      \"pmids\": [\"33186656\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Methylated residues and their effect on NEF activity not mapped\", \"Generality beyond HCC unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Reported a translational-regulatory function in thyroid cancer, with BAG5 modulating FN1 via miR-144-3p to promote invasion.\",\n      \"evidence\": \"Overexpression/knockdown, polysome fractionation, invasion assay, miR-144-3p functional assay\",\n      \"pmids\": [\"32275930\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanistic link between BAG5 and miRNA suppression unclear\", \"Limited detail and single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established BAG5 as a disease gene for inherited dilated cardiomyopathy and defined its cardiac mechanism as HSC70 NEF activity supporting junctional membrane complex structure and calcium handling.\",\n      \"evidence\": \"Human genetics, knock-in mouse phenocopy, JMC localization, calcium assays, AAV9 gene rescue\",\n      \"pmids\": [\"35044787\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the structural folding substrates at the JMC not defined\", \"Why cardiac tissue is selectively vulnerable unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed BAG5 regulates Akt stability by switching Akt from mono- to polyubiquitination, with the complex governed by phosphorylation and growth-factor signaling.\",\n      \"evidence\": \"Co-IP, domain mapping, ubiquitination switch assay, knockdown/overexpression Akt stability readouts\",\n      \"pmids\": [\"38139359\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase mediating the ubiquitination switch not identified\", \"Physiological signaling outcomes of Akt regulation untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined an essential germ-cell role: BAG5 partners HSPA8 to fold SPATA6 and other structural proteins, and its loss causes acephalic spermatozoa and infertility.\",\n      \"evidence\": \"BAG5 knockout mouse, co-IP, in vitro chaperone substrate-affinity assay, spermatid immunofluorescence\",\n      \"pmids\": [\"38454159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BAG5 selects this specific substrate set is unknown\", \"Whether NEF activity alone accounts for folding enhancement unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Provided a second human DCM variant and tied cardiac dysfunction to an impaired ER stress response in vivo.\",\n      \"evidence\": \"Human exome/Sanger sequencing, knock-in mouse with tunicamycin challenge, echocardiography, apoptosis assay\",\n      \"pmids\": [\"38796549\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship between ER stress defect and JMC/calcium phenotype not integrated\", \"Causal UPR branch in the heart not pinpointed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended germline function to earlier stages, showing BAG5 stabilizes HSPA2 in spermatocytes to support nuclear protein exchange and prevent germ cell apoptosis.\",\n      \"evidence\": \"Bag5 knockout mouse, IP-mass spectrometry, co-IP, testis RNA-seq, western blot\",\n      \"pmids\": [\"39992433\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct chaperone substrates of the BAG5-HSPA2 complex not defined\", \"Mechanism linking HSPA2 loss to TNP/PRM transcription unclear\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Reported BAG5 partnering with HSPA1A to promote ATF2 degradation and dampen apoptotic signaling in spermatogenic cells.\",\n      \"evidence\": \"Co-IP-mass spectrometry, co-IP validation, ubiquitination assay, overexpression/knockdown\",\n      \"pmids\": [\"41558067\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single lab with limited independent replication\", \"E3 ligase mediating ATF2 degradation not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how a single BAG5 NEF/co-chaperone activity is mechanistically partitioned to produce opposite outcomes — substrate stabilization versus destabilization, mitochondrial protection versus mitophagy suppression — across its different tissue and substrate contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying structural/biophysical model linking the four BAG domains plus BD5 to context-specific outcomes\", \"Determinants of substrate selection across neurons, heart, germline, and tumor cells unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 7, 13]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [1, 13, 15]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 7, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3, 19]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 13, 15]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [3, 19]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [9, 10]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 3, 9]}\n    ],\n    \"complexes\": [\n      \"BAG5-Hsp70-Parkin complex\",\n      \"BAG5-CHIP-Hsp70-alpha-synuclein complex\",\n      \"BAG5-HSPA8 complex\",\n      \"junctional membrane complex (cardiomyocyte)\"\n    ],\n    \"partners\": [\n      \"HSPA8\",\n      \"Parkin\",\n      \"CHIP\",\n      \"PINK1\",\n      \"GRP78\",\n      \"p62\",\n      \"HSPA2\",\n      \"AKT\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}